Evidence map›Paper›PMID 28984234›Full record

ArticleMicrobiology (Reading, England)2017

Stenotrophomonas maltophilia produces an EntC-dependent catecholate siderophore that is distinct from enterobactin.

Megan Y Nas, Nicholas P Cianciotto

Abstract read
In one paragraph

Article in Microbiology (Reading, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Draft genome sequences ofMicrobiology resource announcements · 2025
    Article
  3. Article
  4. Phase-Specific Antibiotic Resistance Mechanisms in anbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Contribution of fepABMC microbiology · 2025
    Article
  7. Article
  8. Article
  9. Frontiers in microbiology · 2024
    Review
  10. HemU and TonB1 contribute to hemin acquisition inFrontiers in cellular and infection microbiology · 2024
    Article
  11. A guide toFrontiers in cellular and infection microbiology · 2023
    Review
  12. TheMicrobiology spectrum · 2022
    Article
  13. Article
  14. Involvement of theMicrobiology spectrum · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Comparative Genomics ofInternational journal of molecular sciences · 2020
    Article
  20. Modulated Response ofFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Megan Y NasDepartment of Microbiology and Immunology, Northwestern University Medical School, Chicago, IL 60611, USA.
Nicholas P CianciottoDepartment of Microbiology and Immunology, Northwestern University Medical School, Chicago, IL 60611, USA.
Northwestern University · US

Funding

TRAINING PROGRAM IN IMMUNOLOGY &MOLECULAR PATHOGENESIST32AI007476 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Edward Benjamin Thorp · 1996 to 2026
$6.6M
Defining the Siderophore of Stenotrophomonas maltophilia, an Emerging, Multi-Drug Resistant PathogenR21AI125968 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CIANCIOTTO, NICHOLAS P · 2017 to 2018
$418k
Virulence Mechanisms of the Emerging Pathogen Stenotrophomonas maltophiliaR21AI117082 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CIANCIOTTO, NICHOLAS P · 2015 to 2016
$411k
NIAID NIH HHS R21 AI117082NIAID NIH HHS R21 AI125968NIAID NIH HHS T32 AI007476
6 · The paper itself

Abstract

Stenotrophomonas maltophilia, a Gram-negative, multi-drug-resistant bacterium, is increasingly recognized as a key opportunistic pathogen. Thus, we embarked upon an investigation of S. maltophilia iron acquisition. To begin, we determined that the genome of strain K279a is predicted to encode a complete siderophore system, including a biosynthesis pathway, an outer-membrane receptor for ferrisiderophore, and other import and export machinery. Compatible with these data, K279a and other clinical isolates of S. maltophilia secreted a siderophore-like activity when grown at 25-37 °C in low-iron media, as demonstrated by a chrome azurol S assay, which detects iron chelation, and Arnow and Rioux assays, which detect catecholate structures. Importantly, these supernatants rescued the growth of iron-starved S. maltophilia, documenting the presence of a biologically active siderophore. A mutation in one of the predicted biosynthesis genes (entC) abolished production of the siderophore and impaired bacterial growth in low-iron conditions. Inactivation of the putative receptor gene (fepA) prevented the utilization of siderophore-containing supernatants for growth in low-iron conditions. Although the biosynthesis and import loci showed some similarity to those of enterobactin, a well-known catecholate made by enteric bacteria, the siderophore of K279a was unable to rescue the growth of an enterobactin-utilizing indicator strain, and conversely iron-starved S. maltophilia could not use purified enterobactin. Furthermore, the S. maltophilia siderophore displayed patterns of solubility in organic compounds and mobility upon thin-layer chromatography that were distinct from those of enterobactin and its derivative, salmochelin. Together, these data demonstrate that S. maltophilia secretes a novel catecholate siderophore.

Indexed as

Bacterial Outer Membrane ProteinsBacterial ProteinsBiological TransportCarrier ProteinsEnterobactinGenetic Complementation TestIronKineticsMutationReceptors, Cell SurfaceSiderophoresStenotrophomonas maltophiliaTemperatureBacterial Outer Membrane ProteinsBacterial ProteinsCarrier ProteinsEnterobactinIronReceptors, Cell SurfaceSiderophoresEntCenterobactinFepAsalmochelinsiderophoreStenotrophomonas maltophilia

Identifiers

PMID28984234
PMCPMC5845701
OpenAlexW2761441590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.